272 related articles for article (PubMed ID: 21398591)
1. Arrhythmogenic substrate in hearts of rats with monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
Benoist D; Stones R; Drinkhill M; Bernus O; White E
Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2230-7. PubMed ID: 21398591
[TBL] [Abstract][Full Text] [Related]
2. Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat.
Hessel MH; Steendijk P; den Adel B; Schutte CI; van der Laarse A
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2424-30. PubMed ID: 16731643
[TBL] [Abstract][Full Text] [Related]
3. Alterations in pharmacological action of the right ventricle of monocrotaline-induced pulmonary hypertensive rats.
Daicho T; Yagi T; Takano S; Marunouchi T; Abe Y; Ohara M; Takeo S; Tanonaka K
Biol Pharm Bull; 2009 Aug; 32(8):1378-84. PubMed ID: 19652377
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of Kv4.2 and Kv4.3 channel gene expression in right ventricular hypertrophy induced by monocrotaline in rat.
Zhang TT; Cui B; Dai DZ
Acta Pharmacol Sin; 2004 Feb; 25(2):226-30. PubMed ID: 14769214
[TBL] [Abstract][Full Text] [Related]
5. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
[TBL] [Abstract][Full Text] [Related]
6. Right ventricular electrical remodeling and arrhythmogenic substrate in rat pulmonary hypertension.
Tanaka Y; Takase B; Yao T; Ishihara M
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):426-36. PubMed ID: 23600532
[TBL] [Abstract][Full Text] [Related]
7. Effects of telmisartan on right ventricular remodeling induced by monocrotaline in rats.
Okada M; Harada T; Kikuzuki R; Yamawaki H; Hara Y
J Pharmacol Sci; 2009 Oct; 111(2):193-200. PubMed ID: 19809219
[TBL] [Abstract][Full Text] [Related]
8. Right ventricular hypertrophy causes impairment of left ventricular diastolic function in the rat.
Lamberts RR; Vaessen RJ; Westerhof N; Stienen GJ
Basic Res Cardiol; 2007 Jan; 102(1):19-27. PubMed ID: 16944361
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of infantile pulmonary arterial hypertension induced by monocrotaline.
Dias-Neto M; Luísa-Neves A; Pinho S; Gonçalves N; Mendes M; Eloy C; Lopes JM; Gonçalves D; Ferreira-Pinto M; Leite-Moreira AF; Henriques-Coelho T
Pediatr Cardiol; 2015 Jun; 36(5):1000-13. PubMed ID: 25608696
[TBL] [Abstract][Full Text] [Related]
10. Ventricular hypertrophy plus neurohumoral activation is necessary to alter the cardiac beta-adrenoceptor system in experimental heart failure.
Leineweber K; Brandt K; Wludyka B; Beilfuss A; Pönicke K; Heinroth-Hoffmann I; Brodde OE
Circ Res; 2002 Nov; 91(11):1056-62. PubMed ID: 12456492
[TBL] [Abstract][Full Text] [Related]
11. Mechanical load-dependent regulation of gene expression in monocrotaline-induced right ventricular hypertrophy in the rat.
Kögler H; Hartmann O; Leineweber K; Nguyen van P; Schott P; Brodde OE; Hasenfuss G
Circ Res; 2003 Aug; 93(3):230-7. PubMed ID: 12842921
[TBL] [Abstract][Full Text] [Related]
12. Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension.
Falcão-Pires I; Gonçalves N; Henriques-Coelho T; Moreira-Gonçalves D; Roncon-Albuquerque R; Leite-Moreira AF
Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H2007-14. PubMed ID: 19346461
[TBL] [Abstract][Full Text] [Related]
13. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
[TBL] [Abstract][Full Text] [Related]
14. Early changes in rat hearts with developing pulmonary arterial hypertension can be detected with three-dimensional electrocardiography.
Henkens IR; Mouchaers KT; Vliegen HW; van der Laarse WJ; Swenne CA; Maan AC; Draisma HH; Schalij I; van der Wall EE; Schalij MJ; Vonk-Noordegraaf A
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1300-7. PubMed ID: 17496210
[TBL] [Abstract][Full Text] [Related]
15. Ca
Sabourin J; Boet A; Rucker-Martin C; Lambert M; Gomez AM; Benitah JP; Perros F; Humbert M; Antigny F
J Mol Cell Cardiol; 2018 May; 118():208-224. PubMed ID: 29634917
[TBL] [Abstract][Full Text] [Related]
16. Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats.
Tofovic SP; Salah EM; Mady HH; Jackson EK; Melhem MF
J Cardiovasc Pharmacol; 2005 Oct; 46(4):430-7. PubMed ID: 16160593
[TBL] [Abstract][Full Text] [Related]
17. Preservation of diastolic function in monocrotaline-induced right ventricular hypertrophy in rats.
Lamberts RR; Caldenhoven E; Lansink M; Witte G; Vaessen RJ; St Cyr JA; Stienen GJ
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1869-76. PubMed ID: 17604325
[TBL] [Abstract][Full Text] [Related]
18. Sulforaphane Improves Redox Homeostasis and Right Ventricular Contractility in a Model of Pulmonary Hypertension.
Conzatti A; Colombo R; Siqueira R; Campos-Carraro C; Turck P; Luz de Castro A; Belló-Klein A; Sander da Rosa Araujo A
J Cardiovasc Pharmacol; 2024 Jun; 83(6):612-620. PubMed ID: 38547510
[TBL] [Abstract][Full Text] [Related]
19. Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension.
Henriques-Coelho T; Correia-Pinto J; Roncon-Albuquerque R; Baptista MJ; Lourenço AP; Oliveira SM; Brandão-Nogueira A; Teles A; Fortunato JM; Leite-Moreira AF
Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2885-90. PubMed ID: 15331358
[TBL] [Abstract][Full Text] [Related]
20. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
